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The isolation of viruses with mutations in essential genes requires that they be propagated in cells expressing the wild-type
proteins. This has been a particularly challenging problem for studying mutations in the human cytomegalovirus (HCMV)
immediate early (IE) gene, IE2 86. In the past, we tried a number of approaches to derive human fibroblasts expressing
wild-type IE2 86, but were unable to maintain expression of a fully functional protein. To overcome this obstacle, we
developed a strategy whereby recombinant baculoviruses were used as vectors for the expression of HCMV IE proteins in
primary human fibroblasts (FFs). The IE2 86 and IE1 72 cDNAs, as well as the genomic fragment of the UL122-123 region
under the control of a chicken actin promoter, were introduced into the baculovirus genome by site-specific transposition in
Escherichia coli. Recombinant “bacmid” DNAs were then transfected into Sf9 cells to generate recombinant baculoviruses.
FFs infected at high m.o.i. with these baculoviruses expressed high levels of the HCMV protein for at least 1 week, as
determined by immunofluorescence assays and Western blots. Moreover, the IE2 86 protein was found to be fully functional
with respect to its ability to activate the HCMV UL112-113 early promoter. Recombinant baculoviruses expressing IE1 72
were also able to efficiently complement HCMV ie1 mutants. These data demonstrate the potential of using recombinant
baculoviruses as vectors for the expression of toxic viral genes in human cells and for subsequent isolation of mutant HCMV
lacking these essential genes. © 2001 Academic Press
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sINTRODUCTION
Human cytomegalovirus (HCMV), a b-herpesvirus, is
n opportunistic pathogen that causes disease in new-
orns and susceptible immunocompromised individuals
Britt and Alford, 1996). Upon infection, HCMV gene ex-
ression occurs in a temporally regulated fashion (for
eview see Mocarski, 1996). The expression of immedi-
te early (IE) genes is required for the subsequent ex-
ression of early and late genes. Successful replication
n the host is initially dependent upon the appearance of
he IE nuclear phosphoproteins of 72 kDa (IE1 72;
pUL123) and 86 kDa (IE2 86; ppUL122). The RNA tran-
cripts encoding these proteins originate from the major
E enhancer promoter and are alternatively spliced. The
essage for IE1 72 comprises exons 1 to 4, whereas the
E2 86 transcript consists of exons 1 to 3 and 5. Trans-
ation of both proteins is initiated at exon 2, and they
hare 85 amino acids (aa) at their amino termini.
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alifornia Davis Medical Center, Research III, 3200C, Sacramento, CA
5817.
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297The IE1 72 and IE2 86 proteins have been studied in
etail with regard to their roles in regulation of viral and
ellular gene expression (for review see Fortunato and
pector, 1999; Mocarski, 1996). IE1 72 is the most abun-
ant product of the IE region. It can autoregulate the
CMV IE promoter via NF-kb and can associate with
several regulatory proteins, including some TBP-associ-
ated factors, the transcription factor CTF-1, and the Rb-
related protein p107 (Hayhurst et al., 1995; Lukac et al.,
1997; Poma et al., 1996). Coexpression of IE1 72 aug-
ents the regulatory properties of IE2 86, a major trans-
ctivator of HCMV and heterologous promoters. IE2 86
an interact with itself and the viral 75 kDa early protein
UL84), as well as with the components of the basal
ranscription complex (TBP and TFIIB), several TBP-as-
ociated factors, and specific transcription factors and
roducts of the tumor suppressor genes p53 and Rb
Caswell et al., 1993; Chiou et al., 1993; Choi et al., 1995;
Furnari et al., 1993; Hagemeier et al., 1992; Jupp et al.,
1993; Lang et al., 1995; Lukac et al., 1994, 1997; Schwartz
et al., 1996; Scully et al., 1995; Sommer et al., 1994;
Spector and Tevethia, 1994; Speir et al., 1994; Yoo et al.,
996). IE2 86 can also bind to DNA in a site-specific but
equence-tolerant manner (Arlt et al., 1994; Cherrington
et al., 1991; Huang and Stinski, 1995; Liu et al., 1991;
Pizzorno and Hayward, 1990; Rodems et al., 1998;
Schwartz et al., 1994; Scully et al., 1995).
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298 DWARAKANATH ET AL.The properties of the IE proteins have been charac-
terized thus far primarily using in vitro analyses and in
vivo transient expression assays. A more accurate un-
derstanding of IE gene function in the context of viral
replication, however, requires analysis of mutant viruses.
Toward this end, a recombinant virus unable to synthe-
size IE1 72 was isolated by complementing the deficient
protein in an immortalized IE1 72-expressing human fi-
broblast cell line, ihfie 1.3 (Mocarski et al., 1996, Greaves
and Mocarski, 1998). Several groups have attempted to
establish an IE2 86 cell line capable of complementing
ie2 mutants without success. One possible explanation
is that continuous expression of wild-type IE2 86 is del-
eterious for the host cell. This suspicion is further
strengthened by the finding that the one reported fibro-
blast cell line that expresses IE2 86 (Bonin and McDou-
gall, 1997) is unable to significantly transactivate the
HCMV UL112-113 promoter (our unpublished results).
Moreover, it has recently been found that the IE2 86 gene
in these cells has mutations in a critical region of the
protein (Murphy et al., 2000). In addition, our attempts to
generate retroviruses and replication-defective adenovi-
ruses expressing wild-type IE2 86 have been unsuccess-
ful. However, recently Murphy and colleagues have re-
ported success in generating an adenovirus vector ex-
pressing functional IE2 86 when the IE2 86 gene is under
the control of a Tet-inducible promoter (Murphy et al.,
2000).
The baculovirus (Autographa californica nucleopolyhe-
drosis virus, AcNPV) expression system has been widely
used for the synthesis of high levels of foreign proteins in
insect cells (for review see Luckow and Summers, 1988).
The benefit of this system is the production of large
quantities of recombinant proteins with the proper post-
translational modifications. Until recently, the ability of
baculoviruses to infect mammalian cells was only dem-
onstrated in cells of hepatic origin (Boyce and Bucher,
1996). The use of promoters from other viruses to drive
expression of heterologous proteins was also limited to
these cell types. However, the finding that the strong
chicken actin promoter coupled with a rabbit b-globin
poly(A) site (CAG) can drive baculovirus-mediated pro-
tein expression in other mammalian cell types (Shoji et
al., 1997) has opened the possibility of using this system
for expression of HCMV IE proteins in FFs to provide the
complementation necessary to isolate HCMV mutants.
This system provides sustained expression for several
days and the baculoviruses cannot replicate in mamma-
lian cells. Moreover, the heterologous protein is not ex-
pressed during propagation of the baculovirus in insect
cells and is only expressed for a limited time in FFs.
Therefore there is no selection against the wild-type
gene if the protein has any detrimental effects on the
cell.The generation of recombinant baculoviruses by tra-
ditional methods has several drawbacks, including a low
e
Mfrequency of recombination and the requirement for sev-
eral rounds of plaque purification. However, the use of
site-specific transposon-mediated insertion of foreign
genes into a baculoviral genome that is maintained as a
self-replicating episome (bacmid) in Escherichia coli
(Luckow et al., 1993) has greatly facilitated the rapid
generation of recombinant baculoviruses. We have used
this alternative strategy to construct baculoviruses that
were capable of expressing high levels of HCMV IE
proteins in FFs. The recombinant IE2 86 was capable of
transactivating the HCMV UL112-113 promoter, thus
demonstrating that it is a functional protein. Moreover,
the HCMV ie1 mutant CR208 was found to replicate in
FFs expressing IE1 72 from the recombinant baculovirus
with an efficiency that is comparable to that observed in
a complementing fibroblast cell line. Taken together,
these data suggest that it may be possible to isolate
mutants in essential HCMV genes with baculovirus-me-
diated transcomplementation.
RESULTS
Efficient construction of recombinant baculoviruses
containing the HCMV IE cDNAs using
site-specific transposition
The first step toward isolating a viral mutant that lacks
an essential gene is to generate a complementing cell
line that provides all the functions of this gene product.
This approach has been successfully used to generate
several mutant herpesviruses, including an HCMV ie1
mutant (Greaves and Mocarski, 1998; Mocarski et al.,
1996). However, in the case of a promiscuous transacti-
vator similar to IE2 86, whose overexpression in the host
cells has a possible deleterious effect, a different ap-
proach was necessary.
Recombinant baculoviruses were constructed for ex-
pression of HCMV IE genes in FFs (Fig. 1). These bacu-
loviruses have a cassette (referred to as CAG) that has a
composite promoter containing the CMV IE enhancer
and chicken b-actin promoter and a rabbit b-globin poly-
denylation signal (Niwa et al., 1991). The vectors pFast-
acI/CAG-IE72 and pFastBacI/CAG-IE86 (Figs. 1a and
b) have the IE1 72 and IE2 86 cDNAs, respectively,
laced in the CAG cassette downstream of the CA pro-
oter and retain the insect polyhedrin promoter up-
tream of the CA promoter. The construct pFastBacI/IE86
Fig. 1c) has the IE2 86 cDNA placed under the control of
he insect polyhedrin promoter to generate recombinant
aculoviruses expressing the IE2 86 gene product in
nsect cells. Finally, pFastBacI/IE1-2 (Fig. 1d) contains
he UL122-123 region of HCMV cloned downstream of
he CA promoter. Recombinant baculoviruses were gen-
rated via site-specific transposition as described under
aterials and Methods.
pressio
299BACULOVIRUS-MEDIATED EXPRESSION OF HCMV IE PROTEINSIE2 86 and IE1 72 are not expressed in Sf9 cells
infected with Bac CAG-IE86 and Bac CAG-IE72
Since our aim was to generate recombinant baculovi-
ruses that expressed the IE genes in human cells but not
in insect cells, we first analyzed lysates of Sf9 cells
infected with the recombinant baculoviruses derived
from pFastBacI/CAG-IE1-2, pFastBacI/CAG-IE86, and
pFastBacI/CAG-IE72 (BacCAG-IE1-2, Bac CAG-IE86, and
Bac CAG-IE72, respectively) that contain the IE genes
under the control of the CA promoter but with an intact
polyhedrin promoter located further upstream. By West-
FIG. 1. Construction of recombinant baculoviruses for expression in
IE2 86 is driven by the CA promoter in pFastBacI/CAG-IE72 and pF
polyhedrin promoter to drive expression of the IE2 86 cDNA for its ex
HCMV cloned downstream of the CA promoter.ern blot analysis with an antibody that recognizes both IE
proteins, we found that none of these viruses expressedIE2 86 (Fig. 2a, lanes 1, 2; Fig. 2b, lanes 5, 6) or IE1 72
(Fig. 2a, lanes 1, 2; Fig. 2c, lanes 3, 4) in Sf9 cells. As a
control, we show that high levels of recombinant IE2 86
protein were present in Sf9 lysates infected with bacu-
loviruses generated from the vector pFastBacI/IE86 (Bac
IE86) that contains only the polyhedrin promoter (Fig. 2d,
lanes 2, 3, 4).
HCMV IE genes under the control of the CA promoter
in baculovirus are expressed efficiently
in mammalian cells
d Sf9 cells. The expression of the immediate early cDNAs, IE1 72, and
I/CAG-IE86. The construct pFastBacI/IE86 uses the upstream insect
n in Sf9 cells. pFastBacI/CAG-IE1-2 contains the UL122-123 region ofFFs an
astBacAn analysis of the expression of HCMV IE proteins in
mammalian cells was carried out using Bac CAG IE1-2,
300 DWARAKANATH ET AL.Bac CAG-IE86, and Bac CAG-IE72. FFs infected with Bac
CAG-IE1-2 expressed IE2 86 but not IE1 72, as deter-
mined using the CH16.0 antibody (Fig. 2a, lanes 3, 4). IE1
72 was not detected using an antibody that specifically
detects this protein (data not shown), further confirming
that the protein expressed is IE2 86. The reason that IE1
72 is not expressed from this vector could perhaps be
attributed to the presence of the downstream b-globin
polyadenylation signal. Both FFs and HeLa cells infected
with Bac CAG-IE86 expressed recombinant IE2 86 (Fig.
2b, lanes 1–4). Similarly, recombinant IE1 72 was ex-
pressed by FFs infected with Bac CAG-IE72 (Fig. 2c,
FIG. 2. Western analysis of recombinant HCMV IE proteins ex-
pressed by baculoviruses in different cell types. The antibody used was
CH16.0, which recognizes both IE1 and IE2 proteins through a shared
epitope in exon 2. (a) IE2 86 expression from two recombinant bacu-
lovirus clones of Bac CAG-IE1-2 (lanes 1 and 3 represent the first clone,
lanes 2 and 4 represent the second) in Sf9 cells (lanes 1 and 2) and FFs
(lanes 3 and 4). (b) IE2 86 expression from two recombinant baculovirus
clones of Bac CAG-IE86 (lanes 1, 3, and 5 represent the first clone, and
lanes 2, 4, and 6 represent the second) at 48 h.p.i. in FFs (lanes 1 and
2), HeLa cells (lanes 3 and 4), and Sf9 cells (lanes 5 and 6). (c) IE1 72
expression from two recombinant baculovirus clones of Bac CAG-IE72
(lanes 1 and 3 represent the first clone, and lanes 2 and 4 represent the
second) in FFs (lanes 1 and 2), and Sf9 cells (lanes 3 and 4) compared
to mock-infected FFs (M) and ihfie 1.3 cells (ihfie). (d) IE2 86 expression
in Sf9 cells from baculoviruses generated from three different recom-
binant bacmid clones of Bac IE86 (lanes 2, 3, and 4) as compared to
mock-infected Sf9 cells (lane 1). Cells were harvested at 48 h.p.i. (e)
Lysates prepared at 24 h.p.i. from uninfected FFs (lane 1) and FFs
infected with HCMV Towne (lane 2), Bac CAG-IE72 (lane 3), Bac
CAG-IE86 (lane 4), and Bac CAG-IE72 plus Bac CAG-IE86 (lane 5).lanes 1, 2). For comparison, we show the level of expres-
sion of IE1 72 in the ihfie 1.3 cells, which express theprotein constitutively from an integrated retroviral vector
(Fig. 2c, lane 6). As expected, no IE1 72 protein could be
detected in uninfected FFs (Fig. 2c, lane 5).
To use baculoviruses as a complementing system, it
was important to further analyze the levels of recombi-
nant HCMV IE proteins expressed in FFs relative to that
seen in HCMV infected cells. Figure 2e shows the levels
of IE protein in uninfected cells (lane 1) and in cells
infected with HCMV Towne (lane 2), Bac CAG-IE72 (lane
3), Bac CAG-IE86 (lane 4), and both Bac CAG-IE86 and
Bac CAG-IE72 (lane 5). At 24 h.p.i., cells infected with
either of the two baculoviruses expressed the respective
IE protein at levels that were at least as high as those in
HCMV-infected cells (compare lane 2 with lanes 3 and 4).
We did note, however, that a coinfection with both Bac
CAG-IE86 and Bac CAG-IE72 resulted in a small de-
crease in the amounts of the individual proteins (lane 5).
Baculovirus-mediated expression of the HCMV IE pro-
teins in FFs was also examined by immunofluorescence.
High levels of IE1 72 and IE2 86 were detected in the
nuclei of baculovirus infected cells by 24 h.p.i. (Figs. 3a
and 3c, respectively). As controls, cells infected with
HCMV (Fig. 3e) and uninfected cells (Fig. 3g) are shown.
Nuclei were visualized by Hoechst staining (Figs. 3b, 3d,
3f, and 3h). When cells were infected with the recombi-
nant baculovirus at an m.o.i. of 100–200, expression of
the IE proteins could be detected in 60–80% of the cells,
with the percentage of IE1 72 expressing cells being
slightly higher than those expressing IE2 86. In the
course of these studies, we found that it was important
that the cells be infected at a low density as the effi-
ciency of the infection decreased when the cells ap-
proached confluence prior to infection. Therefore in all
experiments the cells were less than 50% confluent
when infected with baculovirus. As detected by immuno-
fluorescence assays, the expression of IE2 86 from Bac
CAG-IE86 persisted for at least 10 days postinfection
(data not shown). One effect that we noted when the
cells were infected at a high m.o.i. (200–400) is that the
cells grew more slowly. In addition, some CPE was noted
when the media was not changed daily.
The recombinant IE2 86 transactivates the HCMV
UL112-113 promoter
The functionality of the IE2 86 expressed by the bac-
ulovirus was analyzed by testing its ability to transacti-
vate the HCMV UL112-113 early promoter. This was done
by using the recombinant Towne HCMV v148 CAT (Ro-
dems et al., 1998), which has the CAT gene cloned
downstream of the UL112-113 promoter in the context of
the US 9–10 region. FFs were either mock infected or
infected with an empty recombinant baculovirus or a
baculovirus expressing the HCMV IE proteins. After al-
lowing 24 h for the accumulation of the IE gene products,
cells were infected with HCMV v148 CAT in the presence
T
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301BACULOVIRUS-MEDIATED EXPRESSION OF HCMV IE PROTEINSof cycloheximide (CHX). The effect of the baculovirus-
expressed IE proteins on the UL112-113 promoter was
analyzed by studying the levels of the CAT transcripts.
CHX was used to block the effects of the IE1 72 and IE2
86 expressed from HCMV v148 CAT. Northern blots of the
RNA samples were probed with 32P-labeled CAT cDNA.
FIG. 3. Immunofluorescence of FFs stained with CH16.0 antibody vie
CAG-IE72 (a and b), Bac CAG-IE86 (c and d), and HCMV Towne (e and
2003 (a, b, c, d) and 1003 (e, f, g, h).he levels of GAPDH mRNA in each lane were used as
reference for the total amount of RNA in each sample.
t
ihe CHX treatment completely blocked translation from
he HCMV v148 CAT genome, as no CAT transcripts were
bserved in the absence of preinfection with baculovirus
Fig. 4, lane 2). FFs that were preinfected with Bac CAG
E86 (lane 5) expressed 18-fold higher levels of CAT
ranscripts as compared to cells preinfected with a con-
ith FITC (a, c, e, g) and DAPI (b, d, f, h) filters. Cells infected with Bac
compared with mock-infected cells (g and h) at 24 h.p.i. Magnification,wed wrol baculovirus, Bac CAG (lane 3). Similarly, those pre-
nfected with Bac CAG-IE1-2 contained 36-fold higher
302 DWARAKANATH ET AL.CAT mRNA (lane 6) over background levels. The effect of
Bac CAG-IE72 on the early promoter was less dramatic
(lane 4) and resulted in a fivefold upregulation. As ex-
pected, no CAT mRNA was detected in uninfected cells
(lane 1). This experiment proved that the HCMV IE pro-
teins produced from a recombinant baculoviral infection
are functional and could potentially be used for comple-
mentation of IE mutants.
Bac CAG-IE72 efficiently complements HCMV ie1
mutants
The use of recombinant baculoviruses as a comple-
mentation system to support the growth of HCMV mu-
tants was further analyzed by testing the replication of
the previously characterized ie1 mutant CR208 (Greaves
and Mocarski, 1998) in FFs infected with Bac CAG-IE72.
This ie1 mutant exhibits a normal pattern of replication in
primary human fibroblasts in high multiplicity infections,
although no IE1 72 protein is present (Greaves and
Mocarski, 1998). However, when FFs are infected at low
multiplicity, the virus is severely growth-restricted.
In the initial experiment, titers of CR208 were deter-
mined in FFs and ihfie 1.3 cells that were first infected
with increasing m.o.i. of Bac CAG-IE72 and incubated for
48 h at 37°C to allow expression of the IE1 gene product.
Bac CAG-IE72-infected and uninfected cells were then
infected with 10-fold serial dilutions of CR208. A compar-
ison of the resultant viral titers is represented in Table 1.
FFs that were not preinfected with Bac CAG-IE72 before
the CR208 infection showed approximately a 100-fold
decrease in the number of plaques on the FFs, as com-
pared to the ihfie 1.3 cells. Upon infection with Bac
CAG-IE72, however, the number of plaques increased in
proportion to the m.o.i.
Optimal complementation was seen when the baculo-
FIG. 4. Northern blots of total RNA samples isolated from FFs that
were either mock infected (lane 1) or infected with HCMV v148 CAT
(lanes 2–6). These cells were either mock preinfected (lanes 1 and 2)
or preinfected with Bac CAG (lane 3), Bac CAG-IE72 (lane 4), Bac
CAG-IE86 (lane 5), or Bac CAG-IE1-2 (lane 6). The CAT transcripts are
indicated with an arrow. GAPDH is shown as a control for RNA loading.viral infection was at an m.o.i. of 200. A further doubling
of the amount of Bac CAG-IE72 resulted in a decrease inthe number of CR208 plaques (data not shown). Exami-
nation of the data obtained with the ihfie 1.3 cells indi-
cated that there was also a gradual decrease in CR208
titers with increasing m.o.i. of the recombinant baculovi-
rus. Similar experiments with wild-type HCMV also re-
sulted in a small decrease in viral titers on FFs and ihfie
1.3 cells as the m.o.i. of Bac CAG-IE72 increased, but in
this case the decrease was first seen when a lower m.o.i.
of Bac CAG-IE72 was used (data not shown). Taken
together, these results suggest that the HCMV infection
may be inhibited somewhat when the amount of the IE
protein or the number of baculovirus genomes in the
cells exceeds a certain threshold.
One concern with these types of experiments is that a
dual infection with baculovirus expressing the wild-type
IE protein and the HCMV mutant virus might lead to the
generation of wild-type HCMV. To verify that Bac CAG-
IE72 and CR208 coinfection did not lead to regeneration
of IE1-positive HCMV, a total of 18 plaques from the
complementation assay were further tested for their abil-
ity to form plaques on FFs and ihfie 1.3 cells. Individual
plaques were resuspended in complete media and se-
rially diluted for parallel infection of FFs and ihfie 1.3
cells. As shown in a representative experiment in Table
2, the plaques from either Bac CAG-IE72 complementa-
tion or the ihfie 1.3 cells resulted in higher titers on ihfie
1.3 cells, as compared to primary fibroblasts. This assay
was also extended to include Sf9 cells to determine
whether the recombinant baculoviruses could replicate
in FFs. However, no plaques were visualized on the
insect cells confirming that these baculoviruses were
indeed replication defective in primary fibroblasts (data
not shown). This concurs with an earlier report that
although the activity of a reporter gene was observed up
to 14 days p.i., there was no detectable infectious bacu-
TABLE 1
Comparison of CR208 Plaque Formation on FFs and ihfie 1.3 Cells
Infected with Increasing Amounts of Bac CAG-IE72
MOI of
Bac CAG-IE72
Number of plaques formed
FFs ihfie 1.3
Relative ml of
undiluted CR208
Relative ml of
undiluted CR208
0.1 0.01 0.001 0.1 0.01 0.001
0 2 —a — TNTCb 58 4
6 8 — — TNTC 36 8
20 34 — — TNTC 42 6
60 286 11 — 380 28 —
200 TNTC 32 4 300 22 —a (—), No plaques visualized.
b TNTC, Too numerous to count.
303BACULOVIRUS-MEDIATED EXPRESSION OF HCMV IE PROTEINSlovirus in mammalian cells after 9 days p.i. (Shoji et al.,
1997).
DISCUSSION
The role of HCMV IE proteins IE1 72 and IE2 86 in the
regulation of gene expression has been studied with
great interest by several investigators (for review see
Fortunato and Spector, 1999; Mocarski, 1996). It is now
evident that both IE1 72 and IE2 86 play key roles in
influencing the transcriptional machinery of the host cell,
as well as that of the virus. The activities of these pro-
teins are achieved by interaction with cellular factors, as
well as DNA binding in the case of IE2 86. Specifically,
IE1 72 can bind several transcription factors, as well as
the Rb-related protein, p107. It can also localize to PML
(promyelocytic leukemia protein)-containing nuclear
bodies (ND10 sites), thereby promoting the dispersal of
PML. This phenomenon has been hypothesized to be the
means by which HCMV utilizes the host cell’s nuclear
architecture for expression of viral gene products (Ahn
and Hayward, 1997; Ishov et al., 1997; Kelly et al., 1995;
see Fortunato and Spector, 1999 for review).
Our lab and others have primarily used transient ex-
pression systems and in vitro binding assays to delin-
eate the functional domains of IE2 86 (reviewed in For-
tunato and Spector, 1999). In this way, it was found that
the terminal 290–579 aa are responsible for autoregula-
tion and DNA binding to its own promoter, as well as to
some viral early promoters. In addition, the homodimer-
ization of IE2 86 and its binding to other cellular proteins
all appear to map to the region of the protein bounded by
aa 86–542. The mapping of the activation domains of IE2
TABLE 2
Titer on FFs and ihfie 1.3 Cells of Virus in CR208 Plaques Resulting
from the Complementation Assays
Amount of virus
(relative ml of
plaque lysate)
Titer (No. of plaques formed)
CR208 from FFs
infected with Bac
CAG-IE72
CR208 from ihfie
1.3 cells
FFs ihfie 1.3 FFs ihfie 1.3
100 550 TNTCa 425 TNTC
10 15 TNTC 32 TNTC
1 2 132 —b 130
Note. CR208 plaques were picked from either Bac CAG-IE72 comple-
mentation or from ihfie 1.3 cells. Each plaque was used to infect both
FFs and ihfie 1.3 cells. The results shown are representative plaque
numbers from six individual plaque lysates, three each from Bac CAG-
IE72-complemented FFs and ihfie 1.3 cells.
a TNTC, Too numerous to count.
b (—), No plaques visualized.86 has been more problematic as the results depend on
the target promoter used as well as the host cells. Workfrom our lab has focused primarily on the domains re-
quired for the activation of the HCMV early UL112-113
promoter and the 1.2-kb promoter in cells permissive for
viral replication (Scully et al., 1995; Sommer et al., 1994).
These studies revealed that sequences between aa
26–85 and aa 290–579 are required for activation of both
promoters. Stimulation of the 1.2-kb promoter also re-
quires aa 86–135.
Although studies carried out so far have revealed a
great deal of information about the functions of the IE
proteins, the physiological significance of these putative
functions can only be determined in the context of the
viral infection by studying replication of viruses contain-
ing mutations in these genes. We and others have used
a gene replacement strategy to construct recombinant
HCMV by replacing a dispensable portion of the unique
short region between the US9 and US10 genes with the
promoter-reporter cassette of interest (Kohler et al., 1994;
Rodems et al., 1998). However, construction of HCMV
lacking the IE genes has been more challenging. The
isolation of the two ie1 mutants RC303DAcc and CR208
using a complementing fibroblast cell line helped eluci-
date the role of IE1 72 protein in the context of the
infection (Greaves and Mocarski, 1998; Mocarski et al.,
1996). During a low m.o.i. infection, these mutants were
severely replication defective. Interestingly, the presence
of IE2 86 at wild-type levels during low m.o.i. infections
did not compensate for the lack of IE1 72. This was
directly reflected in the expression pattern of UL44 (a
processivity factor for the HCMV DNA polymerase),
which was lacking in low m.o.i. infections. Based on
these data, it has been suggested that IE1 72 is respon-
sible for transactivating this early gene, which is required
to establish successful viral replication. Although IE1 72
is a key factor that promotes early infection events, it is
not completely essential because high m.o.i. infections
of the ie1 mutant viruses proceed with wild-type kinetics.
Since one of the major interests in our laboratory has
been the study of gene regulation mediated by IE2 86,
we have tried several different strategies to establish cell
lines that could express the IE2 86 protein. We have also
used viral vectors such as replication-defective adenovi-
ruses and retroviruses to express HCMV IE proteins.
Although we have successfully constructed adenovi-
ruses that express high levels of IE1 72 (R. S. Dwaraka-
nath and D. H. Spector, unpublished results), IE2 86
recombinants could not be isolated. In this paper, we
describe an approach using recombinant baculoviruses
whereby constitutive expression of the HCMV IE1 72 and
IE2 86 proteins can be achieved in primary fibroblasts.
In isolating Bac CAG-IE72 and Bac CAG-IE86, the
baculovirus shuttle vector and bacmid technology was
utilized (Luckow et al., 1993). The recombinant bacmids
that were generated by site-specific transposition in bac-
teria were infectious when introduced into Sf9 cells,
leading to the generation of pure stocks of recombinant
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304 DWARAKANATH ET AL.viruses. The relative ease with which Bac-CAG-IE86 was
constructed is likely due to the fact that the CA promoter
in the virus does not lead to the expression of any
wild-type IE2 86 in the Sf9 cells used for propagating the
recombinant baculovirus. Several different bacmid
clones have been successfully used for the generation of
each recombinant virus. Two major criteria seemed to
influence IE expression in FFs: first, the m.o.i. at which
the baculoviruses were used; and second, the confluent
state of the cells. A careful optimization of both these
factors revealed that when FFs were plated so that they
were less than 50% confluent, greater than 60–70% of the
cells expressed the foreign proteins. The level of IE
protein expression under such conditions is comparable
to that of a wild-type HCMV infection, where all the cells
in culture express the IE proteins.
In our laboratory, the UL112-113 promoter has been
routinely used to study the functionality of the IE2 86
protein (Klucher et al., 1993; Rodems et al., 1998;
Schwartz et al., 1996; Sommer et al., 1994; Staprans et al.,
1988). The recombinant virus HCMV v148 CAT (Rodems
et al., 1998) was therefore used to demonstrate high
levels of transactivation of the early promoter by the
recombinant IE proteins generated from recombinant
baculoviruses. Higher levels of transactivation were ob-
served when IE2 86 was expressed from the genomic
fragment than from the cDNA. This may be due to the fact
that the genomic fragment is from strain AD169, while the
origin of the cDNA is the Towne strain of HCMV.
In view of the advantages discussed here, recombi-
nant baculoviruses could be used for the in vivo analysis
of individual HCMV proteins. In support of this argument,
we have recently reported the use of Bac CAG-IE72 and
Bac CAG-IE86 to analyze the effect of HCMV IE expres-
sion on HCMV-mediated cyclin E induction (McElroy et
al., 2000). Specifically, we demonstrated that these IE
proteins were not sufficient for the upregulation of cyclin
E levels that is observed during HCMV infection.
The complementation assays carried out with Bac
CAG-IE72 document the applicability of the recombinant
baculovirus technology for propagating mutant HCMV.
We have addressed several issues in the design of these
assays. First, the use of Bac CAG-IE72 in FFs resulted in
CR208 titers comparable to the IE1 expressing cell line,
ihfie 1.3. Increasing amounts of IE1 72 in FFs provided by
Bac CAG-IE72 caused a corresponding increase in the
number of CR208 plaques. However, above a certain
m.o.i., a decrease in viral replication was observed. The
presence of very high amounts of Bac CAG-IE72 inhib-
ited plaque formation of CR208 as well as HCMV Towne
in both cell types. This effect could be caused by the
elevated levels of IE1 72 protein or possibly by a syner-
gistic antiviral effect due to the elevated levels of inter-
feron-a and -b that may be generated in baculovirus
infected cells (Gronowski et al., 1999). Second, Bac CAG-
IE72 complementation did not result in any undesired
l
precombination events that could generate wild-type
HCMV from CR208.
One of the recent advancements in herpesvirus biol-
ogy has been the cloning of the HCMV genome as an
infectious bacterial artificial chromosome (BAC) and the
use of site-directed, transposon-mediated mutagenesis
to produce HCMV mutants in this system (Borst et al.,
1999; Brune et al., 1999; Delecluse et al., 1998; Messerle
et al., 1997; Wagner et al., 1999). This technology, coupled
with bacmid-mediated generation of recombinant bacu-
loviruses, now provides a new strategy for efficiently
isolating viruses with mutations in essential genes.
MATERIALS AND METHODS
Cells and viruses
Suspension cultures of Spodoptera frugiperda (Sf) 9
cells were grown in Grace’s insect cell culture medium
(GIBCO-BRL) supplemented with 10% heat-inactivated
FBS (GIBCO-BRL), 200 U of penicillin (Omega Scientific),
200 mg of streptomycin (Omega Scientific), and 6.0 mg of
mphotericin B (Omega Scientific) per milliliter and used
or the propagation of all AcNPVs. Human FFs (obtained
rom the University of California, San Diego, Medical
enter) and HeLa cells were grown in minimal essential
edium (MEM) with Earle’s salts supplemented with 10%
BS, 2 mM L-glutamine (Bio-Whittaker), 200 U of penicil-
lin, 200 mg of streptomycin, 50 mg of gentamicin (Omega
cientific), and 1.5 mg of Amphotericin B per milliliter. The
E1 72 expressing ihfie 1.3 cells (Greaves and Mocarski,
998; Mocarski et al., 1996) were provided by Dr. Edward
ocarski (Stanford University) and grown in the media
escribed above that was also supplemented with 400
mg of geneticin (GIBCO-BRL) per milliliter. HCMV Towne
strain was obtained from American Type Culture Collec-
tion (VR 977) and propagated as previously described
(Tamashiro et al., 1982). The ie1 deletion mutant CR208
(Greaves and Mocarski, 1998) was a generous gift from
Dr. Edward Mocarski. Unless otherwise noted, ihfie 1.3
cells were used for the propagation of these mutant
viruses and determination of their titers by plaque assay.
Molecular cloning
The pAdex1CAwt cosmid (Miyake et al., 1996) was a
generous gift from Dr. Yumi Kanegae. The 2.3-kb IE2 86
cDNA was excised from pSGIE86 (Klucher et al., 1993)
with BamHI, end repaired with Klenow enzyme, and
subcloned into the SwaI site of the cosmid vector
pAdex1Cawt yielding pAdex/IE86. In this construct, the
IE2 86 cDNA is placed downstream of the chicken actin
promoter and upstream of the rabbit b-globin polyade-
ylation signal. The CAG-IE86 cassette was then excised
rom pAdex/IE86 with PmeI, EcoRI linkers (Stratagene)
ere added to the blunt ends, and this fragment was
igated into the EcoRI site of baculovirus transfer vector
FastBac1 (GIBCO-BRL) to give pFastBacI/CAG-IE86.
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305BACULOVIRUS-MEDIATED EXPRESSION OF HCMV IE PROTEINSA control vector for the expression of IE2 86 in Sf9
cells, pFastBacI/IE86, was derived by subcloning the
BamHI fragment of the IE2 86 cDNA from pSGIE86 into
the BamHI site of pFastBac1.
The construct pFastBacI/CAG-IE72 was derived using
an alternate strategy. The CAG cassette was excised
from pAdex1CAwt by PmeI digestion and then ligated
into the StuI site of pFastBac1 to yield pFastBacI/CAG.
he orientation of the CAG fragment in this construct was
erified by restriction analysis. The IE1 72 cDNA frag-
ent was excised from pSGIE72 (Klucher et al., 1993) by
BamHI digestion, end repaired with Klenow enzyme, and
ligated into the SwaI site of pFastBacI/CAG to give pFast-
BacI/CAG-IE72. The orientation of the IE1 72 cDNA with
reference to the CAG cassette was further confirmed by
restriction analysis.
The vector pFastBacI/CAG-IE1-2 was constructed to
express wild-type IE2 86 from the genomic fragment of
the UL122-123 region. This was done by subcloning the
EcoRI fragment of the genomic DNA from pSGIE1-2
(Klucher et al., 1993) into the SwaI site of pFastBacI/CAG.
Recombinant bacmid preparation
The BAC-TO-BAC system was purchased from GIBCO-
BRL. In this system, recombinant baculoviruses are gen-
erated by Tn7-mediated site-specific transposition of the
expression cassette into a baculovirus expression vec-
tor. The baculoviral genome is maintained as a bacmid,
a low-copy-number episome in E. coli DH10 Bac cells.
The bacmid contains a kanamycin-resistance marker
and a lacZ gene, so that transposition can be monitored
by blue–white color selection. Transposition events dis-
rupt the lacZ coding sequence, resulting in white colo-
nies. DH10 Bac cells containing wild-type bacmids were
transformed with vectors pFastBacI/CAG-IE1-2, pFast-
BacI/CAG-IE86, pFastBacI/IE86, or pFastBacI/CAG-IE72.
The resultant white colonies were used for isolation of
recombinant bacmid DNA. The presence of the high
molecular weight (.135 kb) bacmid DNA was confirmed
by agarose gel electrophoresis before the bacmids were
used for transfecting Sf9 cells.
Recombinant baculovirus amplification and titering
Recombinant bacmids were introduced into Sf9 cells
using CellFECTIN (GIBCO-BRL). Briefly, 9 3 105 log
hase cells were seeded onto 35-mm tissue culture
lates and allowed to attach for at least 1 h. Cells were
ashed in serum-free media before the DNA–lipid com-
lexes were overlaid onto the cells. After a 5 h incubation
t room temperature, the cells were washed and incu-
ated with fresh media. The recombinant baculovirus
as harvested from the cell culture medium at 72 h
osttransfection. The culture supernatants were clarified
y centrifugation and virus stocks were stored in the
ark at 4°C. Amplification of viral stocks was carried outy infecting Sf9 monolayers at a m.o.i. of 0.1–1.0. Culture
upernatants were harvested 4–6 days postinfection,
nd the titers of recombinant baculoviruses were deter-
ined by plaque assay on Sf9 monolayers (Rodems and
riesen, 1993).
nfection of FFs with recombinant baculoviruses
FFs were seeded onto tissue culture dishes to 50%
onfluence and allowed to attach at 37°C for 2 h. The
ulture media was aspirated and the viral inoculum (Sf9
ulture supernatants made up to the required volume
ith complete DMEM) overlaid in a volume of 0.2–0.5 ml.
nfection was carried out at room temperature for 1 h.
he inoculum was removed completely and replaced
ith fresh media. Cells were incubated at 37°C and
arvested at the indicated times for Western blot and
mmunofluorescence analyses.
estern blot analysis
Cell pellets were resuspended in PBS and the cells
ere lysed by five freeze/thaw cycles. Protein content in
amples was determined with the BioRad reagent before
oiling with reducing Laemmli buffer (2% SDS, 10% glyc-
rol, 100 mM DTT, 60 mM Tris, pH 6.8, 2 mg/ml of
aprotinin and leupeptin, 1mM PMSF, 50 mM NaF, 0.5 mM
Na3VO4, 4 mM EDTA, 10 mM Na2P2O7, 1 mM benzami-
ine, and 1 mM Na2S2O5). Samples were then electro-
phoresed on 10% SDS–polyacrylamide gels and trans-
ferred onto an Immobilon P (Millipore) membrane. Filters
were probed with a mouse monoclonal antibody, CH16.0
(Goodwin Institute), which is specific for HCMV IE1 72
and IE2 86, at a dilution of 1:20,000. The HRP-linked
secondary anti-mouse IgG antibody (1:5000, Calbio-
chem) was detected using chemiluminescent methods
(Supersignal, Pierce).
Immunofluorescence of infected FFs
Cells were grown on coverslips and infected with the
recombinant baculoviruses as described above. Cover-
slips were washed twice with PBS, simultaneously fixed
and permeabilized in cold methanol for 10 min at 220°C,
and then rinsed three times with PBS. The HCMV IE
proteins were detected using the CH16.0 antibody as
previously described (McElroy et al., 2000). Slides were
viewed under a Zeiss fluorescence microscope and the
images were captured with an MTT CCD2 camera using
NIH image software. Images were then processed using
Adobe Photoshop 3.0 and Adobe Illustrator 8.0.
RNA analysis
FFs infected with either Bac CAG-IE72, Bac CAG-IE86,
or Bac CAG-IE1-2 were allowed to express the recombi-
nant IE protein. At 24 h.p.i., they were treated with cyclo-
heximide at a concentration of 100 mg/ml for 3 h. The
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306 DWARAKANATH ET AL.cells were then washed and infected in the presence of
CHX with a recombinant HCMV Towne that expresses
the chloramphenicol acetyl transferase (CAT) gene prod-
uct under the control of the UL112-113 early promoter
(v148CAT, Rodems et al., 1998). At 7 h post-v148CAT
infection, cells were harvested by trypsinization and total
RNA was isolated using the Trizol reagent (Life Technol-
ogies). Twenty micrograms of each sample was electro-
phoresed on a denaturing formaldehyde agarose gel
according to standard protocols. The gel was transferred
to a nylon membrane and the RNA hybridized to DNA
probes labeled with 32P using Prime-It II (Stratagene).
Phosphorimager (Molecular Dynamics) analysis was
performed to quantify the strength of the signal.
Complementation assays
FFs or ihfie 1.3 (a total of 106 cells/dish) were seeded
onto separate 24-well dishes and allowed to settle for 2 h
at 37°C. Cultures were either mock infected with Sf9
culture supernatants or infected with the recombinant
baculovirus expressing IE1 72 as described above.
Plaque assays were then carried out on these cells
24–48 h.p.i. with the recombinant baculovirus. Tenfold
serial dilutions of either HCMV Towne or the ie1 mutant
viruses were assayed. The viral inoculum was aspirated
after 24 h, and the cells were overlaid with 0.5% agarose
in MEM Earle’s media. Viral plaques were counted be-
tween 9–11 days after infection and titers calculated.
Results shown are mean values derived from two to
three independent experiments.
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